Clinical Trial Update: Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda [Phase 3]

View source ↗

Summary

A Phase 3 trial in Uganda evaluating optimal chemopreventive regimens to prevent malaria and improve birth outcomes has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: Grant Dorsey, M.D, Ph.D. | Conditions: Malaria | Phase 3 | Status: COMPLETED | Results posted: 2025-11-06